The Long Read: Innovation, Access & Affordability in the USA
A Tale of Two Americas The US stands as the biopharma innovation champion of the world, a global leader on nearly all R&D indices related to…
Tagged with Biocon
Hot Topics in US Healthcare & Pharma
So far in 2020 PharmaBoardroom has conducted interviews with several key stakeholders in US healthcare. We have heard from leaders the US FDA, as well…
Biocon’s Recipe for Success in the Competitive US Generics…
Indian firm Biocon has seen great success in the US in recent years, with two biosimilar launches and a range of generic medicines now available on…
Abhijit Zutshi – Commercial Head Global Generics & SVP…
Abhijit Zutshi, commercial head global generics & SVP marketing at Indian firm Biocon highlights the challenges inherent in the US generics…
Biocon’s New Facility & Expansion in APAC
Biocon, the first Indian company to have a biosimilar drug approved in the US, is taking another step forward with a new manufacturing facility and an…
PharmaBoardroom’s Women to Watch
Annually, PharmaBoardroom conducts hundreds of interviews with global CEO’s, country managers and industry leaders in the pharma industry. While we…
Indian Biosimilars: Going Global
Deloitte predicts that the global market for biosimilars will reach between USD 25 and 35 billion by 2020, driven by some key global biologic drugs…
Interview: Kiran Mazumdar-Shaw – Chairwoman and Managing…
A pioneer of the biotechnology industry in India and the head of the country’s leading biotechnology enterprise, Kiran Mazumdar-Shaw, discusses the…
Gender Diversity in Indian Pharma
India could boost its GDP by USD 0.7 trillion in 2025 by matching the rate of improvement of gender equality of the leading country in its region.…
Interview: Alexander Willemse – CEO, BioConnection BV, The…
The CEO of BioConnection, the leading contract services and manufacturing organization for the development and production of injectable…
Interview: Kiran Mazumdar-Shaw, Chairman & Managing…
If we look back at the conditions under which you founded Biocon in 1978, we see a young woman with a seed capital of only Rs. 10,000 in a garage in…
Interview with Alexander Willemse, CEO, BioConnection
In addition to highlighting company strategies and strengths in our reports, we also like to get a feel for the leaders within the local markets that…
